Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)

Vinita Dhir, Caseng Zhang, Nick Barrowman, Ewa Sucha, Rachael F. Grace, John D. Grainger, Nancy L Young, Robert J. Klaassen

Blood (2023) 142 (Supplement 1): 1215.

https://doi.org/10.1182/blood-2023-182449

Published: 2023

Journal Articles

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

Gregory A. Abel, Robert Klaassen, Stephanie J. Lee, Nancy L. Young, Laura Cannella, David P. Steensma, Fabio Efficace

Blood (2014) 123 (3): 451–452.

https://doi.org/10.1182/blood-2013-11-540021

Published: 2014

Journal Articles

Comparison of Dosimetry and Gamma Camera Methods for Evaluation of Biodistribution Prior to Administration of the Therapeutic Dose of Tositumomab and Iodine I 131 Tositumomab (Bexxar Therapeutic Regimen)

Thierry J. Horner, PhD, Jeffry A. Siegel, MS, MS, PhD, Roxanne C. Jewell, PhD, Gary J. Lunger, MSRIS, RT(R)(N)ARRT, Nancy L. Young, BS, NMT, Brian R. Wynne, MD, Vanessa C. Williams, MS, Thomas S. Lin, MD, PhD, Mark S. Kaminski, MD, Richard L. Wahl, MD, Christina Vleisides, DC

Blood (2010) 116 (21): 4916.

https://doi.org/10.1182/blood.V116.21.4916.4916

Published: 2010

Journal Articles

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Robert Klaassen, MD, John D. Grainger, MD, Arne Riedlinger, M.Phil., Victor S. Blanchette, MD, Tricia Burke, BA, Estela Citrin, MD, Gustavo Dufort y Alvarez, MD, Petronella Rachieru, MD, Josué Rakotonjanahary, MPH, Gerhard Gaedicke, MD, Cindy D. Wakefield, RN, Nancy L. Young, PhD

Blood (2009) 114 (22): 2501.

https://doi.org/10.1182/blood.V114.22.2501.2501

Published: 2009

Journal Articles

Outcome Measures in Childhood Idiopathic Thrombocytopenic Purpura: Relationship of Bleeding Severity, Quality of Life, and Platelet Count.

Cindy E. Neunert, MD, George R. Buchanan, MD, Victor S. Blanchette, MD, Dorothy R. Barnard, MD, Nancy L. Young, PhD, Christine Curtis, MSc, Robert J. Klaassen, MD

Blood (2006) 108 (11): 1079.

https://doi.org/10.1182/blood.V108.11.1079.1079

Published: 2006

NARROW

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

Comparison of Dosimetry and Gamma Camera Methods for Evaluation of Biodistribution Prior to Administration of the Therapeutic Dose of Tositumomab and Iodine I 131 Tositumomab (Bexxar Therapeutic Regimen)

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Outcome Measures in Childhood Idiopathic Thrombocytopenic Purpura: Relationship of Bleeding Severity, Quality of Life, and Platelet Count.

Email alerts

ASH Publications

American Society of Hematology

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

Comparison of Dosimetry and Gamma Camera Methods for Evaluation of Biodistribution Prior to Administration of the Therapeutic Dose of Tositumomab and Iodine I 131 Tositumomab (Bexxar Therapeutic Regimen)

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Outcome Measures in Childhood Idiopathic Thrombocytopenic Purpura: Relationship of Bleeding Severity, Quality of Life, and Platelet Count.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only